Skip to main content

Peter Pronovost, Justin Norden, and Kedar Mate emphasize that senior leaders must take daily responsibility for AI governance in hospitals rather than leaving it to a technology committee that meets infrequently.

Opinion: Who's Ensuring Proper Oversight of AI in Hospitals?

CMS aims to create a standardized payment model for clinical software and AI that emphasizes their effectiveness in improving patient outcomes.

CMS Plans New Payment Framework for Clinical Software and AI

Prediction markets, long established in sports, politics, and entertainment, are now making their way into the biopharma sector. This innovation aims to apply market-based forecasting to clinical trials and FDA approval outcomes, potentially transforming how drug development risks and timelines are assessed.

Kalshi Targets Biopharma with Prediction Markets for Clinical Trials and FDA Approvals

The Trump administration initiated a pilot program using artificial intelligence to streamline Medicare approvals for certain medical services, but efforts to end this test have been blocked by the GOP.

GOP Opposes Ending Medicare AI Prior Authorization Pilot

Deepfakes are rapidly eroding the trust essential for digital healthcare services such as telehealth and patient portals. These convincing but fake representations of medical professionals threaten the integrity and reliability that patients depend on when seeking remote care and accessing personal health information online.

Opinion: When Your Doctor's Digital Double Isn't Really Your Doctor

AI is transforming the field of medicine. The physicians responsible for patient outcomes need to be at the forefront of how AI is integrated into healthcare, ensuring it benefits patient care effectively and ethically—as emphasized by Afnan R. Tariq and Ami Bhatt.

Rethinking AI Licensure: Physicians Must Guide Its Role in Medicine

Today's health technology highlights include a nationwide rollout of virtual physical therapy, insights into the FDA's evolving stance on AI regulations, and other notable industry updates.

FDA Digital Chief Signals Upcoming AI Policy Changes

Edison Scientific is collaborating with investment firm Population Health Partners to utilize AI agents for accelerating drug discovery and development in the biotechnology sector. This partnership aims to harness cutting-edge AI technology to create new biotechnological solutions and enhance the efficiency of pharmaceutical research and development.

Edison Scientific Partners with Population Health Partners to Advance AI-Driven Biotech Innovations

Portugal's National Health Service has entered into an agreement with digital health firm Sword Health to implement AI-assisted virtual physical therapy across the country, aiming to enhance patient care and accessibility.

Portugal's National Health Service Partners with Sword Health for AI-Driven Virtual Physical Therapy

Clive Meanwell, chairman of Population Health Partners, once skeptical about AI, now views it as a powerful catalyst in advancing biotechnologies designed for improving population health.

Investor Clive Meanwell on Shaping Biotech for Population Health and AI as a Game-Changer